4/A//SEC Filing
Narula Sanjeev 4/A
Accession 0001193125-25-234650
CIK 0001783183other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 5:09 PM ET
Size
5.3 KB
Accession
0001193125-25-234650
Insider Transaction Report
Form 4/AAmended
Narula Sanjeev
Chief Financial & Bus. Officer
Transactions
- Award
Common Stock
2025-10-06+144,000→ 144,000 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted on October 6, 2025. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of October 6, 2025, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]This amendment is being filed to report the transaction which was inadvertently omitted in the Form 4 filed on behalf of the Reporting Person on October 7, 2025.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001820590
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 5:09 PM ET
- Size
- 5.3 KB